127 related articles for article (PubMed ID: 16640176)
1. [Recommendations for follow-up of malignant diseases].
Eckert R
Praxis (Bern 1994); 2006 Apr; 95(15):567-73. PubMed ID: 16640176
[TBL] [Abstract][Full Text] [Related]
2. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis.
Edelman MJ; Meyers FJ; Siegel D
J Gen Intern Med; 1997 May; 12(5):318-31. PubMed ID: 9159703
[TBL] [Abstract][Full Text] [Related]
3. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II.
Blanchard CM; Courneya KS; Stein K;
J Clin Oncol; 2008 May; 26(13):2198-204. PubMed ID: 18445845
[TBL] [Abstract][Full Text] [Related]
4. Follow-up care for cancer: making the benefits equal the cost.
Schwartz D; Billingsley K; Wallner K
Oncology (Williston Park); 2000 Oct; 14(10):1493-8, 1501; discussion 1502-5. PubMed ID: 11098513
[TBL] [Abstract][Full Text] [Related]
5. [Standards, Options and Recommendations (SOR): clinical practice guidelines for diagnosis, treatment and follow-up of cutaneous melanoma. Fédération Nationale des Centres de Lutte Contre le Cancer].
Négrier S; Fervers B; Bailly C; Beckendorf V; Cupissol D; Doré JF; Dorval T; Garbay JR; Vilmer C
Bull Cancer; 2000 Feb; 87(2):173-82. PubMed ID: 10705288
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials referral resource. Non-small-cell lung cancer.
Cheson BD
Oncology (Williston Park); 1990 Feb; 4(2):51-63. PubMed ID: 2167113
[No Abstract] [Full Text] [Related]
7. Clinical trials referral resource.
Cheson BD; Ungerleider RS
Oncology (Williston Park); 1992 Nov; 6(11):30, 32, 34-6. PubMed ID: 1332740
[No Abstract] [Full Text] [Related]
8. Immunotherapy of cancer.
Salmon SE; Jones SE
Ariz Med; 1977 Jun; 34(6):396-8. PubMed ID: 880051
[No Abstract] [Full Text] [Related]
9. Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma.
Perez EA; Loprinzi CL; Sloan JA; Owens DT; Novotny PJ; Bonner JA
Cancer; 1997 Aug; 80(4):676-80. PubMed ID: 9264350
[TBL] [Abstract][Full Text] [Related]
10. Quality assessment in oncology.
Albert JM; Das P
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):773-81. PubMed ID: 22445001
[TBL] [Abstract][Full Text] [Related]
11. The ASCO experience with evidence-based clinical practice guidelines.
Smith TJ; Somerfield MR
Oncology (Williston Park); 1997 Nov; 11(11A):223-7. PubMed ID: 9430192
[TBL] [Abstract][Full Text] [Related]
12. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.
Winawer SJ; Zauber AG; Fletcher RH; Stillman JS; O'Brien MJ; Levin B; Smith RA; Lieberman DA; Burt RW; Levin TR; Bond JH; Brooks D; Byers T; Hyman N; Kirk L; Thorson A; Simmang C; Johnson D; Rex DK; ;
Gastroenterology; 2006 May; 130(6):1872-85. PubMed ID: 16697750
[TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".
Pflugfelder A; Kochs C; Blum A; Capellaro M; Czeschik C; Dettenborn T; Dill D; Dippel E; Eigentler T; Feyer P; Follmann M; Frerich B; Ganten MK; Gärtner J; Gutzmer R; Hassel J; Hauschild A; Hohenberger P; Hübner J; Kaatz M; Kleeberg UR; Kölbl O; Kortmann RD; Krause-Bergmann A; Kurschat P; Leiter U; Link H; Loquai C; Löser C; Mackensen A; Meier F; Mohr P; Möhrle M; Nashan D; Reske S; Rose C; Sander C; Satzger I; Schiller M; Schlemmer HP; Strittmatter G; Sunderkötter C; Swoboda L; Trefzer U; Voltz R; Vordermark D; Weichenthal M; Werner A; Wesselmann S; Weyergraf AJ; Wick W; Garbe C; Schadendorf D; ;
J Dtsch Dermatol Ges; 2013 Aug; 11 Suppl 6():1-116, 1-126. PubMed ID: 24028775
[TBL] [Abstract][Full Text] [Related]
15. Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H).
Csatary LK; Moss RW; Beuth J; Töröcsik B; Szeberenyi J; Bakacs T
Anticancer Res; 1999; 19(1B):635-8. PubMed ID: 10216468
[TBL] [Abstract][Full Text] [Related]
16. Adherence to cancer treatment guidelines: influence of general and cancer-specific guideline characteristics.
Heins MJ; de Jong JD; Spronk I; Ho VKY; Brink M; Korevaar JC
Eur J Public Health; 2017 Aug; 27(4):616-620. PubMed ID: 28013246
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy from malignant disease.
Goodnight JE; Morton DL
Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
[No Abstract] [Full Text] [Related]
18. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials referral resource. NCI-sponsored trials of interleukin-6 (IL-6).
Cheson BD; Carter CL; Sznol M
Oncology (Williston Park); 1993 Jun; 7(6):43-4. PubMed ID: 8391298
[No Abstract] [Full Text] [Related]
20. The current approach to cancer treatment.
Hurley TH; Sullivan JR; Bell R
Aust Fam Physician; 1977 Aug; 6(8):951-6. PubMed ID: 72559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
